Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 251 to 260 of 2555

TitleReference numberPublishedLast updated
Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosisTA1018
Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and overTA1019
Endoscopic bipolar radiofrequency ablation for malignant biliary obstructionHTG731
Elafibranor for previously treated primary biliary cholangitisTA1016
Alectinib for adjuvant treatment of ALK-positive non-small-cell lung cancerTA1014
Teclistamab for treating relapsed and refractory multiple myeloma after 3 or more treatmentsTA1015
Endometriosis: diagnosis and managementNG73
Avapritinib for treating advanced systemic mastocytosisTA1012
Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devicesHTG730
Danicopan with ravulizumab or eculizumab for treating paroxysmal nocturnal haemoglobinuriaTA1010

Results per page

  1. 10
  2. 25
  3. 50
  4. All